Cargando…
MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer
Recent studies have shown that the mediator complex (MED) plays a vital role in tumorigenesis and development, but the role of MED16 (mediator complex subunit 16) in breast cancer (BC) is not clear. Increasing evidence has shown that the mTOR pathway is important for tumour progression and therapy....
Autores principales: | Li, Han, Li, Kang, Shu, Dan, Shen, Meiying, Tan, Zhaofu, Zhang, Wenjie, Pu, Dongyao, Tan, Wenhao, Tang, Zhenrong, Jin, Aishun, Liu, Shengchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604881/ https://www.ncbi.nlm.nih.gov/pubmed/36294896 http://dx.doi.org/10.3390/life12101461 |
Ejemplares similares
-
Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer
por: Xu, Yingkun, et al.
Publicado: (2022) -
Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022) -
Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
por: Xu, Yingkun, et al.
Publicado: (2022) -
CSC-3436 switched tamoxifen-induced autophagy to apoptosis through the inhibition of AMPK/mTOR pathway
por: Wu, Sheng-Tang, et al.
Publicado: (2016) -
mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)